go-v.orgdoi

A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance

Sha Zhu, Vinit Shanbhag, Yanfang Wang, Jaekwon Lee, Michael J. Petris · Journal of Cancer · 2017

  • DOI 10.7150/jca.19029
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2017

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2017

Abstract

The ATP7A protein is a ubiquitously expressed copper-translocating P-type ATPase that controls cytoplasmic copper concentrations by mediating cellular copper egress.In vitro studies have previously demonstrated that ATP7A abundance in various tumor cell lines is correlated with increased resistance to cisplatin, a widely-used chemotherapy agent.However, to date no studies have examined a role for ATP7A in tumor growth or cisplatin sensitivity in vivo.In this study, we deleted ATP7A in H-RAS transformed tumorigenic mouse embryonic fibroblasts (MEF RAS 7A-).Interestingly, loss of ATP7A was found to markedly suppress tumorigenesis in MEF RAS 7A-cells relative to wild type parental cells.This was associated with hyperaccumulation of copper and sensitivity to reactive oxygen species and hypoxia.Tumor grafts lacking ATP7A were markedly more sensitive to cisplatin chemotherapy compared to ATP7A-expressing control tumors.These findings identify ATP7A at the nexus between tumorigenesis and cisplatin resistance pathways, underscoring its potential as a therapeutic target for regulating both tumor growth and the efficacy of cisplatin treatment.

Open the resolved locator · 10.7150/jca.19029

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 00:27 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v08p1952.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.